Page last updated: 2024-08-26

arsenic and Angiogenesis, Pathologic

arsenic has been researched along with Angiogenesis, Pathologic in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.22)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (53.33)	29.6817
2010's	18 (40.00)	24.3611
2020's	2 (4.44)	2.80

Authors

Authors	Studies
Wang, W; Zhang, J; Zhang, Y; Zhang, Z	1
Dongbin, X; Hulai, W; Jing, S; Jingke, Z; Xiaoxia, X; Yanying, Z; Yonggang, T	1
Fu, Y; Guo, BB; Jiang, HY; Li, S; Liu, LY; Wang, KK; Wu, CJ; Zhang, CM; Zhang, F; Zhang, Y	1
Chen, B; Cui, P; Hai, Y; Li, H; Li, Y; Song, P; Wang, X; Wu, Z; Xie, Q; Yu, L; Zhao, L	1
Chahardouli, B; Ghavamzadeh, A; Mohammadi Kian, M; Mohammadi, S; Nikbakht, M; Rostami, S; Tavallaei, M; Zahedpanah, M	1
Backen, A; Clamp, A; Cummings, J; Dawson, M; Dive, C; Farmer, H; Fisher, N; Halbert, G; Halford, S; Harris, A; Hasan, J; Hogg, P; Horsley, L; Jayson, GC; Kumaran, G; Little, R; Middleton, M; Parker, GJ; Potter, P; Roberts, C; Saunders, M; Shaw, D; Smith, N; Smythe, J; Taylor, A; Turner, H; Ward, T; Watson, Y	1
Chen, YR; Dou, MM; Li, PC; Yang, S; Zhang, J; Zhao, XY	1
Fu, HQ; Huang, MW; Wang, K; Wang, KY; Wu, LQ; Yin, XB; Yu, X; Zhou, F	1
Chen, K; Huang, H; Li, B; Sun, GY; Yang, MH; Zang, YS; Zhao, XW	1
Jiang, F; Li, Y; Li, Z; Liu, Q; Shen, J; Wang, X; Zhang, J	1
Chen, S; Ding, W; Kim, S; Pan, M; Tong, Y; Zhang, L; Zhang, X	1
Cao, Z; Chen, X; Cui, L; Gao, B; Zhang, S; Zhang, W	1
Gao, Q; Krebsbach, PH; Kumar, P; Ning, Y; Polverini, PJ; Wang, Z	1
Corti, A; Dilda, PJ; Hogg, PJ; Pompella, A; Ramsay, EE	1
Gotlib, J; Oh, ST	1
Chen, BA; Liu, L; Qin, SK	1
Chen, YJ; Li, HM; Li, XJ; Li, ZH; Liang, Y; Long, Y; Qing, C; Yu, M; Zhang, XM; Zhang, YL	1
Abboud, CN; Cashen, AF; DiPersio, JF; Gao, F; Hassan, A; Klco, JM; Procknow, E; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Welch, JS; Westervelt, P	1
Aguayo, A; Armillas-Canseco, FM; Martínez-Baños, D	1
Dick, LJ; Elliott, MA; Farmer, H; Ford, SJ; Halbert, GW; Hogg, PJ; Prasad, E	1
Creighton, B; Decollogne, S; Dilda, P; Don, AS; Donoghue, N; Flynn, E; Folkman, J; Hogg, PJ; Kisker, O; Zhao, X	1
Bertola, A; Boccadoro, M; Bruno, B; Giaccone, L; Massaia, M; Palumbo, A; Rotta, M	1
Sekeres, MA	1
Cardinale, G; Gervasi, F; Pagnucco, G	1
Alimoghaddam, K; Ghavamzadeh, A; Jahani, M; Rostami, S; Sanaat, Z; Shariftabrizi, A; Tavangar, M; Tavangar, SM	1
Decollogne, S; Dilda, PJ; Hogg, PJ; Rossiter-Thornton, M	1
He, W; Hu, Y; Sun, C; Wang, Y; Zhang, X	1
Dong, X; Jiang, H; Krissansen, GW; Liu, B; Pan, S; Qiao, H; Sun, X	1
Chen, X; Liu, SX; Ren, LF; Wu, DD; Xiao, YF	1
Atchison, WD; Barchowsky, A; Edwards, JR; Nebert, DW; Prozialeck, WC; Woods, JM	1
Dong, X; Liu, Y; Sun, X; Zhang, J; Zhang, X; Zhao, S; Zou, H	1
Dias, S; Lam, G; Lane, WJ; Rafii, S; Roboz, GJ; Soignet, SL; Warrell, RP	1
Hussein, MA	1
List, AF	1
Davison, K; Mann, KK; Miller, WH	1
Jiang, BH; Liu, J; Liu, LZ; Wang, YF; Zhao, L	1
Humphries, B; Jiang, Y; Wang, Z; Xiao, H; Yang, C	1
Barchowsky, A; Chandra, AG; Clark, KA; Gao, X; Li, S; Pagano, PJ; Ross, MA; Stolz, DB; Straub, AC	1
Carpenter, RL; Jiang, BH; Jiang, Y; Jing, Y; Liu, LZ; Peiper, SC	1
Barchowsky, A; Bauer, JA; Klei, LR; Mayka, D; Nemec, AA; Soucy, NV	1
Clark, C; Curilla, S; Green, DE; Hamilton, JW; Ihnat, MA; Kamat, CD; Sturup, S; Warnke, L	1
Barchowsky, A; Klei, LR; Ross, MA; Soucy, NV; Stolz, DB; Straub, AC; Vin, H	1
Barchowsky, A; Hernández-Zavala, A; Klei, LR; Ross, MA; Soucy, NV; Stolz, DB; Straub, AC	1
Antich, PP; He, J; Hermanne, A; Jennewein, M; Kodibagkar, VD; Kulkarni, P; Lewis, MA; Mason, RP; O'Kelly, S; Rösch, F; Slavine, N; Thorpe, PE; Tsyganov, E; Watkins, L; Zhao, D	1
Knapp, A; Stern, GA	1

Reviews

9 review(s) available for arsenic and Angiogenesis, Pathologic

Article	Year
Potential molecular mechanisms underlying the effect of arsenic on angiogenesis. Archives of pharmacal research, 2019, Volume: 42, Issue:11 Topics: Antineoplastic Agents; Arsenicals; Carcinogens; Cell Line, Tumor; Cytokines; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelial Cells; Environmental Exposure; Humans; Infusions, Intravenous; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; PPAR gamma; Receptors, Calcitriol; Signal Transduction; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Vitamin D	2019
Antiangiogenesis in myelodysplastic syndrome. Current cancer drug targets, 2011, Volume: 11, Issue:9 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Arsenic Trioxide; Arsenicals; Bevacizumab; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Lenalidomide; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Receptors, Vascular Endothelial Growth Factor; Thalidomide	2011
New drugs for treatment of multiple myeloma. The Lancet. Oncology, 2004, Volume: 5, Issue:7 Topics: 2-Methoxyestradiol; Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Diphosphonates; Enzyme Inhibitors; Estradiol; Humans; Multiple Myeloma; Neovascularization, Pathologic; Oxides; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Thalidomide	2004
Arsenic trioxide as a treatment for myelodysplastic syndrome. Current hematology reports, 2005, Volume: 4, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Cell Division; Clinical Trials as Topic; Dexamethasone; DNA-Binding Proteins; Drug Therapy, Combination; Glutathione; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; MDS1 and EVI1 Complex Locus Protein; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Proto-Oncogenes; Transcription Factors	2005
Targeting multiple myeloma cells and their bone marrow microenvironment. Annals of the New York Academy of Sciences, 2004, Volume: 1028 Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Boronic Acids; Bortezomib; Cell Adhesion; Cytokines; Disease Progression; Disease-Free Survival; Humans; Ligands; Multiple Myeloma; Neovascularization, Pathologic; Oxides; Protease Inhibitors; Pyrazines; Signal Transduction; Thalidomide	2004
The vascular system as a target of metal toxicity. Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 102, Issue:2 Topics: Animals; Arsenicals; Blood Vessels; Cadmium Compounds; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Lead; Lead Poisoning; Neovascularization, Pathologic	2008
Nontraditional cytotoxic therapies for relapsed/refractory multiple myeloma. The oncologist, 2002, Volume: 7 Suppl 1 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cell Adhesion Molecules; Cytokines; Humans; Multiple Myeloma; Neovascularization, Pathologic; Oxides; Pyrazines; Thalidomide; Treatment Outcome	2002
New approaches to the treatment of myelodysplasia. The oncologist, 2002, Volume: 7 Suppl 1 Topics: Amifostine; Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Azacitidine; Enzyme Inhibitors; Humans; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Prognosis; Proto-Oncogene Mas; Risk Factors; Severity of Illness Index; Thalidomide; Topotecan; Treatment Outcome	2002
Arsenic trioxide: mechanisms of action. Seminars in hematology, 2002, Volume: 39, Issue:2 Suppl 1 Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Division; Glutathione; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neovascularization, Pathologic; Oncogene Proteins, Fusion; Oxides; Recurrence	2002

Trials

4 trial(s) available for arsenic and Angiogenesis, Pathologic

Article	Year
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours. Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Arsenicals; Cell Proliferation; Dose-Response Relationship, Drug; Female; Glutathione; Humans; Infusions, Intravenous; Liver Function Tests; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neovascularization, Pathologic	2013
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study. American journal of hematology, 2011, Volume: 86, Issue:9 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Azacitidine; Bone Marrow; Bone Marrow Cells; Cohort Studies; Decitabine; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Young Adult	2011
Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for Phase I clinical trial. International journal of pharmaceutics, 2012, Apr-15, Volume: 426, Issue:1-2 Topics: Angiogenesis Inhibitors; Antioxidants; Arsenicals; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Compounding; Drug Stability; Freeze Drying; Glutathione; Glycine; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Neoplasms; Neovascularization, Pathologic; Oxidation-Reduction; Potentiometry; Technology, Pharmaceutical; Time Factors	2012
Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia. Leukemia & lymphoma, 2006, Volume: 47, Issue:1 Topics: Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow; Disease Progression; Female; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Neovascularization, Pathologic; Oxides; Recurrence; Remission Induction; Survival Rate; Time Factors; Treatment Outcome	2006

Other Studies

32 other study(ies) available for arsenic and Angiogenesis, Pathologic

Article	Year
Realgar Nanoparticles Inhibit Migration, Invasion and Metastasis in a Mouse Model of Breast Cancer by Suppressing Matrix Metalloproteinases and Angiogenesis. Current drug delivery, 2020, Volume: 17, Issue:2 Topics: Animals; Antineoplastic Agents; Arsenicals; Cell Line, Tumor; Cell Movement; Female; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic; Sulfides; Wound Healing	2020
Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis. Molecular medicine reports, 2018, Volume: 17, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Male; Mice, Nude; Neovascularization, Pathologic; Oxides; Xenograft Model Antitumor Assays	2018
Realgar transforming solution suppresses angiogenesis and tumor growth by inhibiting VEGF receptor 2 signaling in vein endothelial cells. Archives of pharmacal research, 2018, Volume: 41, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Arsenicals; Carcinogenesis; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Neovascularization, Pathologic; Signal Transduction; Sulfides; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish	2018
Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells Asian Pacific journal of cancer prevention : APJCP, 2018, Apr-27, Volume: 19, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Leukemia, Myeloid, Acute; Neovascularization, Pathologic; Oxides; Thalidomide; U937 Cells; Vascular Endothelial Growth Factors	2018
Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo. PloS one, 2014, Volume: 9, Issue:6 Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Synergism; Humans; Male; Mice; Necrosis; Neovascularization, Pathologic; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Burden; Xenograft Model Antitumor Assays	2014
Inhibitory effect of humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma: in vitro and in vivo studies. Asian Pacific journal of tropical medicine, 2014, Volume: 7, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Delivery Systems; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Microvessels; Nanoparticles; Neovascularization, Pathologic; Oxides; Single-Chain Antibodies; Vascular Endothelial Growth Factor Receptor-2	2014
Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis. Current cancer drug targets, 2014, Volume: 14, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Angiogenesis Inhibitors; Animals; Arsenic Trioxide; Arsenicals; Calcium-Binding Proteins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Oxides; Receptor, Notch1; Signal Transduction; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2014
Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Toxicology letters, 2014, Nov-18, Volume: 231, Issue:1 Topics: 3' Untranslated Regions; Angiogenesis Inhibitors; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; MicroRNAs; Neovascularization, Pathologic; Neovascularization, Physiologic; NF-kappa B; Oxides; RNA Interference; Signal Transduction; Smad3 Protein; Time Factors; Transfection; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2014
Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo. Drug design, development and therapy, 2015, Volume: 9 Topics: Animals; Antigens, CD; Antineoplastic Agents; Arsenicals; beta Catenin; Cadherins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Signal Transduction; Sp1 Transcription Factor; Stomach Neoplasms; Sulfides; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2015
Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide. Molecular medicine reports, 2016, Volume: 13, Issue:3 Topics: Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Liver Neoplasms; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Oxides; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; V-Set Domain-Containing T-Cell Activation Inhibitor 1; Vascular Endothelial Growth Factor A	2016
Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone. Molecular cancer therapeutics, 2008, Volume: 7, Issue:7 Topics: Animals; Arsenic Trioxide; Arsenicals; Bone and Bones; Bone Resorption; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Mouth Neoplasms; Neoplasm Metastasis; Neovascularization, Pathologic; Osteoblasts; Oxides; Radiation, Ionizing; Treatment Outcome; Tumor Stem Cell Assay; Vascular Endothelial Growth Factor A	2008
Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous acid. The Journal of biological chemistry, 2008, Dec-19, Volume: 283, Issue:51 Topics: Angiogenesis Inhibitors; Animals; Arsenicals; Biological Transport; Cattle; Cells, Cultured; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Endothelial Cells; gamma-Glutamyltransferase; Glutathione; Male; Mitochondria, Liver; Mitochondrial ADP, ATP Translocases; Neovascularization, Pathologic; Organic Anion Transporters; Rats; Rats, Wistar	2008
Antiangiogenic therapy in myelodysplastic syndromes: is there a role? Current hematologic malignancy reports, 2008, Volume: 3, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arsenic Trioxide; Arsenicals; Bevacizumab; Clinical Trials as Topic; Drug Approval; Farnesyltranstransferase; Hematologic Neoplasms; Humans; Lenalidomide; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Protein-Tyrosine Kinases; Thalidomide	2008
[Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2011, Volume: 31, Issue:1 Topics: Amphibian Venoms; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Oxides; Phytotherapy; Xenograft Model Antitumor Assays	2011
Arsenic trioxide induces apoptosis of Burkitt lymphoma cell lines through multiple apoptotic pathways and triggers antiangiogenesis. Oncology research, 2011, Volume: 19, Issue:3-4 Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Burkitt Lymphoma; Cell Proliferation; Flow Cytometry; Humans; Inhibitor of Apoptosis Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Neovascularization, Pathologic; Oxides; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survivin; Vascular Endothelial Growth Factor A	2011
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. Cancer cell, 2003, Volume: 3, Issue:5 Topics: Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Adenosine Triphosphate; Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Arsenicals; Biotin; Calcium; Cattle; Cell Division; Cell Survival; Chick Embryo; Cytosol; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Eosine Yellowish-(YS); Female; Immunohistochemistry; Ion Channels; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Microscopy, Fluorescence; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Chemical; Neovascularization, Pathologic; Peptides; Time Factors	2003
Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity. Cancer research, 2005, Dec-15, Volume: 65, Issue:24 Topics: Angiogenesis Inhibitors; Animals; Aorta; Arsenicals; Cattle; Cell Proliferation; Endothelium, Vascular; Female; Glutathione; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Mitochondrial ADP, ATP Translocases; Multidrug Resistance-Associated Proteins; Neovascularization, Pathologic; Pancreatic Neoplasms; Stereoisomerism; Superoxides; Toluene	2005
Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2006, Volume: 26, Issue:1 Topics: Angiogenesis Inhibitors; Arsenic Trioxide; Arsenicals; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Multiple Myeloma; Neovascularization, Pathologic; Oxides; Receptor, trkB	2006
Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer science, 2006, Volume: 97, Issue:7 Topics: Animals; Antineoplastic Agents; Aorta; Apoptosis; Arsenic Trioxide; Arsenicals; Cattle; Cell Proliferation; Endothelial Cells; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oxides; Vascular Endothelial Growth Factor A	2006
Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer. World journal of gastroenterology, 2006, Sep-28, Volume: 12, Issue:36 Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Oxides; RNA, Messenger; Stomach Neoplasms; Time Factors; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2006
Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Brain Neoplasms; Drug Stability; Glioma; Injections, Intravenous; Liposomes; Male; Microscopy, Electron; Neovascularization, Pathologic; Oxides; Rats; Rats, Wistar; Tissue Distribution	2008
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood, 2000, Aug-15, Volume: 96, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Leukemia; Neovascularization, Pathologic; Oxides; Time Factors	2000
Human endothelial cells promote arsenic-transformed lung epithelial cells to induce tumor growth and angiogenesis through interleukin-8 induction. Aging, 2022, 03-03, Volume: 14, Issue:5 Topics: Arsenic; Bronchi; Cell Movement; Cell Proliferation; Culture Media, Conditioned; Endothelial Cells; Epithelial Cells; Humans; Interleukin-8; Neoplasms; Neovascularization, Pathologic; Receptors, Interleukin-8A	2022
Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway. Toxicology and applied pharmacology, 2013, Aug-15, Volume: 271, Issue:1 Topics: Animals; Arsenic; beta Catenin; Bronchi; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Up-Regulation; Vascular Endothelial Growth Factor A	2013
Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. The Journal of clinical investigation, 2008, Volume: 118, Issue:12 Topics: Animals; Arsenic; Cell Differentiation; Cells, Cultured; Endothelial Cells; Free Radical Scavengers; Gene Expression Regulation; Hypertension, Portal; Liver; Liver Cirrhosis; Membrane Glycoproteins; Mice; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Neovascularization, Pathologic; Neuropeptides; Platelet Endothelial Cell Adhesion Molecule-1; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Superoxides; Water Pollutants, Chemical	2008
Role and mechanism of arsenic in regulating angiogenesis. PloS one, 2011, Volume: 6, Issue:6 Topics: Arsenic; Cell Line, Tumor; Enzyme Activation; Epithelial Cells; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Time Factors; Vascular Endothelial Growth Factor A	2011
Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovascular toxicology, 2005, Volume: 5, Issue:1 Topics: Angiogenic Proteins; Animals; Arsenic; Coronary Vessels; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic	2005
Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicological sciences : an official journal of the Society of Toxicology, 2005, Volume: 86, Issue:2 Topics: Animals; Arsenic; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Nude; Myocardium; Neoplasm Transplantation; Neovascularization, Pathologic; Signal Transduction; Skin Neoplasms; Transcription Factors; Tumor Burden; Vascular Endothelial Growth Factor A	2005
Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice. Toxicology and applied pharmacology, 2007, Aug-01, Volume: 222, Issue:3 Topics: Animals; Arsenic; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Fluorescent Antibody Technique; Inflammation; Laminin; Leukocytes; Liver Circulation; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microvilli; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Poisons; Proteoglycans	2007
Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver. Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:1 Topics: Animals; Arsenic; Blood Vessels; Capillaries; Caveolin 1; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium; Gene Expression Regulation; Laminin; Liver; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Neuropeptides; Platelet Endothelial Cell Adhesion Molecule-1; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Vasoconstriction	2007
Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Mar-01, Volume: 14, Issue:5 Topics: Animals; Antibodies, Monoclonal; Arsenic; Endothelium, Vascular; Male; Neovascularization, Pathologic; Phosphatidylserines; Positron-Emission Tomography; Prostatic Neoplasms; Radioimmunodetection; Radioisotopes; Rats; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2008
Iatrogenic peripheral corneal disease. International ophthalmology clinics, 1986,Winter, Volume: 26, Issue:4 Topics: Antipyrine; Arsenic; Contact Lenses; Contrast Media; Cornea; Corneal Diseases; Gold; Humans; Iatrogenic Disease; Insect Proteins; Neovascularization, Pathologic; Nylons; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Postoperative Complications; Proteins; Silk; Sutures	1986